| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 727646 | 1191406001 | BAQSIMI 3 MG POLVO NASAL EN ENVASE UNIDOSIS | BAQSIMI 3 MG POLVO NASAL EN ENVASE UNIDOSIS, 1 envase unidosis | 3 mg/dosis | 37 | 1 | 37 | 1 envase unidosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191406001/1191406001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191406001/1191406001_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16616 | 16616 | 2020-01-17 | 1 | 1 | 1 | 2020-01-18 | 2020-01-17 | 1 | 2020-12-11 | View Edit Delete | ||||||||||||
| 825992 | 64584 | DOLORAC 600 mg POLVO PARA SUSPENSION ORAL | DOLORAC 600 mg POLVO PARA SUSPENSION ORAL, 20 sobres | 600 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64584/64584_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64584/64584_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27143 | 27143 | 2002-02-22 | 1 | 1 | 1 | 2002-02-22 | 2002-02-22 | 1 | 2020-10-19 | View Edit Delete | ||||||||||||
| 848002 | 64582 | NORVECTAN 600 MG POLVO PARA SUSPENSION ORAL | NORVECTAN 600 MG POLVO PARA SUSPENSION ORAL, 20 sobres | 600 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64582/64582_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64582/64582_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27143 | 27143 | 2002-02-22 | 1 | 1 | 1 | 2002-02-22 | 2006-03-10 | 1 | 2012-01-02 | 825786 | View Edit Delete | |||||||||||
| 848101 | 64584 | DOLORAC 600 mg POLVO PARA SUSPENSION ORAL | DOLORAC 600 mg POLVO PARA SUSPENSION ORAL, 40 sobres | 600 mg | 35 | 40 | 64 | 40 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64584/64584_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64584/64584_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27143 | 27143 | 2002-02-22 | 1 | 1 | 1 | 2002-02-22 | 2006-03-10 | 1 | 2020-10-19 | 752907 | View Edit Delete |